US Patent Issued to GENSUN BIOPHARMA on Sept. 2 for "Bispecific antagonist comprising a LAG-3 binding domain" (California Inventors)

ALEXANDRIA, Va., Sept. 3 -- United States Patent no. 12,404,336, issued on Sept. 2, was assigned to GENSUN BIOPHARMA INC. (Newbury Park, Calif.).

"Bispecific antagonist comprising a LAG-3 binding domain" was invented by Jackie Sheng (Thousand Oaks, Calif.), Margaret Karow (Santa Rosa Valley, Calif.) and Wei Zhang (Thousand Oaks, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Antitumor antagonists that bind specifically to immune checkpoint regulator are disclosed. Also disclosed is a method of treating proliferative disorders with the anti-tumor antagonists."

The patent was filed on April 25, 2023, under Application No. 18/306,562.

*For further information, including images, charts and tables, pleas...